Metabolic positron emission tomography imaging in cancer detection and therapy response
Positron emission tomography (PET) is a noninvasive imaging technique that provides a
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …
functional or metabolic assessment of normal tissue or disease conditions. Fluorine 18 …
Molecular imaging in cancer treatment
MH Michalski, X Chen - European journal of nuclear medicine and …, 2011 - Springer
The success of cancer therapy can be difficult to predict, as its efficacy is often predicated
upon characteristics of the cancer, treatment, and individual that are not fully understood or …
upon characteristics of the cancer, treatment, and individual that are not fully understood or …
Esophageal and esophagogastric junction cancers
JA Ajani, JS Barthel, DJ Bentrem, TA D'Amico… - Journal of the National …, 2011 - jnccn.org
Esophageal and Esophagogastric Junction Cancers in: Journal of the National
Comprehensive Cancer Network Volume 9 Issue 8 (2011) Jump to Content User Account …
Comprehensive Cancer Network Volume 9 Issue 8 (2011) Jump to Content User Account …
Fluorodeoxyglucose positron emission tomography for evaluating early response during neoadjuvant chemoradiotherapy in patients with potentially curable …
M van Heijl, JM Omloo… - Annals of …, 2011 - journals.lww.com
Background: Neoadjuvant chemoradiotherapy before surgery can improve survival in
patients with potentially curable esophageal cancer, but not all patients respond …
patients with potentially curable esophageal cancer, but not all patients respond …
Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital
L Carnevali, B Krug, F Amant… - Annals of …, 2013 - journals.sagepub.com
Background: Medication-related harm can be detected using the adverse drug event (ADE)
trigger tool and the medication module of the Global Trigger Tool (GTT) developed by the …
trigger tool and the medication module of the Global Trigger Tool (GTT) developed by the …
S3-Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus (Langversion 1.0–September 2015, AWMF-Registernummer …
R Porschen, A Buck, W Fischbach… - Zeitschrift für …, 2015 - thieme-connect.com
Die Medizin unterliegt einem fortwährenden Entwicklungsprozess, sodass alle Angaben,
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …
insbesondere zu diagnostischen und therapeutischen Verfahren, immer nur dem …
S3-Leitlinie–Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des ösophagus
R Porschen, W Fischbach, I Gockel… - Zeitschrift für …, 2019 - thieme-connect.com
Thieme E-Journals - Zeitschrift für Gastroenterologie / Full Text DE EN Home Products Journals
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …
Books Book Series Service Library Service Help Contact Portal Zeitschrift für Gastroenterologie …
The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction
AG Little, AE Lerut, DH Harpole… - The Annals of …, 2014 - annalsthoracicsurgery.org
Methods Our Task Force was tasked with addressing the factors affecting the treatment of
locoregional esophageal cancers. This clearly includes patients with stage III disease …
locoregional esophageal cancers. This clearly includes patients with stage III disease …
Can 18F-fluorodeoxyglucose positron emission tomography predict responses to neoadjuvant therapy in oesophageal cancer patients? A meta-analysis
Y Chen, X Pan, L Tong, Y Shi… - Nuclear medicine …, 2011 - journals.lww.com
Objectives Neoadjuvant therapy for the treatment of oesophageal cancer was introduced in
an effort to improve prognosis. Response assessment is crucial for the treatment of patients …
an effort to improve prognosis. Response assessment is crucial for the treatment of patients …
Prognostic values of mid-radiotherapy 18F-FDG PET/CT in patients with esophageal cancer
N Kim, H Cho, M Yun, KR Park, CG Lee - Radiation Oncology, 2019 - Springer
Background To identify whether early metabolic responses as determined using 18 F-
fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) …
fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) …